X4 Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
CEOPaula S. Ragan, PhD
CEOPaula S. Ragan, PhD
Employees143
Employees143
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2010
Founded2010
Employees143
Employees143
XFOR Key Statistics
Market cap338.82M
Market cap338.82M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume751.77K
Average volume751.77K
High today$4.00
High today$4.00
Low today$3.84
Low today$3.84
Open price$3.89
Open price$3.89
Volume562.60K
Volume562.60K
52 Week high$26.83
52 Week high$26.83
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
X4 Pharmaceuticals(XFOR) stock is priced at $3.88, giving the company a market capitalization of 338.82M. It carries a P/E multiple of -0.39.
On 2025-12-12, X4 Pharmaceuticals(XFOR) stock traded between a low of $3.84 and a high of $4.00. Shares are currently priced at $3.88, which is +1.0% above the low and -3.0% below the high.
The X4 Pharmaceuticals(XFOR)'s current trading volume is 562.6K, compared to an average daily volume of 751.77K.
During the past year, X4 Pharmaceuticals(XFOR) stock moved between $1.35 at its lowest and $26.83 at its peak.
During the past year, X4 Pharmaceuticals(XFOR) stock moved between $1.35 at its lowest and $26.83 at its peak.
People also own
Based on the portfolios of people who own XFOR. This list is generated using Robinhood data, and it’s not a recommendation.